Mirum Pharmaceuticals, Inc.
MIRM
Rangering i aksjer
#3223
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Aksjekurs
$85.12
Sist synkronisert: 2026-10-20
Markedsverdi
$5.53B
Endring (1 dag)
3.50%
Endring (1 år)
23.39%
Land
US
Handel Mirum Pharmaceuticals, Inc. (MIRM)
Kategori
Healthcare
Historikk for aksjesplitt for Mirum Pharmaceuticals, Inc. (MIRM)
Aksjen Mirum Pharmaceuticals, Inc. (symbol: MIRM) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én MIRM-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 MIRM-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én MIRM-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 MIRM-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
